ClinicalTrials.Veeva

Menu

Efficacy of Corneal Cross-Linking (CXL) in the Treatment of Pediatric Keratoconus

A

Al-Azhar University

Status

Completed

Conditions

Keratoconus

Treatments

Procedure: Crosslinking

Study type

Interventional

Funder types

Other

Identifiers

NCT07080983
Pediatric Keratoconus

Details and patient eligibility

About

This prospective interventional study investigates the efficacy of corneal cross-linking (CXL) in managing progressive keratoconus in pediatric patients. The procedure involved standard epithelium-off CXL, and patients were followed to assess outcomes such as visual acuity, keratometric stability, and corneal thickness.

Enrollment

20 patients

Sex

All

Ages

10 to 20 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 8 and 18 years
  • Clinical and topographic diagnosis of keratoconus based on the Belin/Ambrosio Enhanced Ectasia Display
  • Evidence of progression within the past 6-12 months (e.g., an increase in maximum keratometry (Kmax) by ≥1.0 diopter, a decrease in minimal corneal thickness by ≥10 µm, or deterioration in visual acuity not attributable to other causes

Exclusion criteria

  • Corneal scarring or opacities.
  • Active ocular infection or inflammation.
  • Prior ocular surgery or trauma.
  • Autoimmune or connective tissue disorders.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Cross-linking
Other group
Treatment:
Procedure: Crosslinking

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems